Lotte Vanmaele2 AF 4

Omega Pharma - Financial analysis

Index

•Omega Pharma

•Top brands

•Financial analysis

•Omega Pharma on the stockmarket

•Conclusion

Omega Pharma?

• Belgian Pharmaceutical Company

• Foundation: 1987 (By Marc Coucke, Yvan Vindevogel)

• Headquarter: Nazareth, Belgium

• Employees: 2.000

• Operations: 35 countries

• Euronext Brussels & BEL20 Index

• PLC

Top brands 2010

Sales: 27 m.

Sales: 33 m. Sales: 12 m.

Sales: 18 m.

Financial Analysis

Financial Analysis

Financial Analysis

2007 2008 2009

-5,000,000

0

5,000,000

10,000,000

15,000,000

20,000,000

Omega Pharma

TurnoverOperating loss, profit

Financial year

Valu

es

in €

Financial Analysis

SHORT OVERVIEW OF THE FIRST QUARTERS IN 2009 AND 2010

Quarter 1 (2010) Quarter 2 (2009) Growth %

Turnover 423,5 411,2 +3%

Operational costs 165,7 156,3 +6%

Net operating profit 33,6 39,0 -14%

Net operating earnings per share

1,44 1,67 -14%

Average number of shares 23.347.309 23.347.309 0%

Values expressed in million €

Financial Analysis

PERFORMANCE BY REGION: TURNOVER

Quarter 1 (2010) Quarter 1 (2009) Growth %

West Europe 175,8 174,9 +1%

Belgium 124,6 112,0 +11%

Growth markets (East Eur. & Turkey) 46,4 41,0 +13%

France 76,7 83,3 -8%

GROUP 423,5 411,2 +3%

Values expressed in million €

Financial Analysis - Geographical breakdown

EBITDA: : Earnings Before Interest, Taxes, Depreciation, Amortization

Emerging markets

13%

West-Eu-rope40%

Belgium28%

France19%

Turnover by region

Omega Pharma on the stockmarket

Share price evolution 1998-2010

Conclusion

•Strong company

•Large name reputation

•Strong product brands

•Sell in 35 countries

•Share prices

THE END

Thank you for watching this slidecast

Lotte Vanmaele

Sources

www.omega-pharma.be

www.nbb.be

www.wikipedia.nl